3-Phenyl-quinoxaline-2-carboxylic acid ethyl ester, 95.0%, 1g

Dipropylene glycol monobutyl ether, min 98%, for synthesis, 1L, plastic packaging.

1-(2-chlorobenzyl)-1H-pyrazole-4-carboxylic acid, 10g

Mirtazapine-d3, 1mg

Quinazolin-8-ol, 95.0%, 250mg

Benzenemethanamine, 4-[4-[4-(trifluoromethoxy)phenyl]-1-piperidinyl]-, 98%, 5g

1-Naphthyl vinyl ketone, 98%, 1g

(3-Chloro-5-(trifluoromethyl)phenyl)boronic acid, 95.0%, 1g

Acetamide, N-(2,5-dimethylphenyl)-2,2,2-trifluoro-, 98%, 1g

3,6-Dibromo-9-(2-ethylhexyl)carbazole>98.0%(GC)5g

Trimethyl(pentafluorophenyl)silane>98.0%(GC)5g

(3-(Benzyloxy)-2-fluoro-5-(trifluoromethyl)phenyl)methanol, 98%, 500mg

Ethyl pyrazine-2-carboxylate, 95.0%, 250mg